Koers Critical Outcome Technologies Inc. Other OTC
Aandelen
CA22675B1031
Biotechnologie & Medisch Onderzoek
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 1,61 mln. 1,48 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -3,68 mln. | Nettowinst (verlies) 2019 | -2 mln. -1,84 mln. | EV/omzet 2018 | - |
Nettoliquiditeiten 2018 | 40,73K 37,44K | Nettoliquiditeiten 2019 | 24,64K 22,65K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-1,11
x | K/w-verhouding 2019 |
-0,6
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 69,18% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 12-06-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 01-07-18 | |
John C. Drake
CHM | Chairman | - | 20-02-07 |
Alison D. Silva
PSD | President | 46 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,73% | 121 mld. | |
+13,04% | 107 mld. | |
-5,80% | 24,82 mld. | |
+1,69% | 22,48 mld. | |
-10,09% | 18,32 mld. | |
-40,52% | 16,33 mld. | |
-14,00% | 15,31 mld. | |
+1,18% | 14,08 mld. | |
+24,18% | 11,74 mld. |